Company Email Format Management

Abcuro, Inc

Biotechnology Research 53 employees

Employees: 53
Contacts: 3
Emails: 3
Phones: 1

abcuro.com LinkedIn Crunchbase

Abcuro, Inc Overview

Phone Number: Available in AeroLeads
Website: abcuro.com
Industry: Biotechnology Research
Employees: 53
Funding: 200.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in this area will be a valuable addition as we continue to advance our clinical programs.

About Abcuro, Inc

Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class anti-KLRG1 antibody designed to deplete cytotoxic T cells that attack healthy muscle tissue in patients with inclusion body myositis (IBM), into clinical studies. IBM is a progressive and debilitating inflammatory skeletal muscle condition with no available pharmaceutical therapies. Abcuro has received FDA orphan drug designation for ABC008 in IBM. The company is also advancing ABC015, an anti-KLRG1 blocking antibody capable of reactivating inhibited cytotoxic T and NK cells in the tumor microenvironment.

Abcuro, Inc Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Abcuro, Inc Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jeff Geary	Director, Human Resources	Newton, Massachusetts, United States	Email
Mark Pruzanski, Ma, Md		New York, United States	Email Phone
Ming Fang	Redmile Group		View
Emiliana Fields		San Francisco Bay Area, United States	Email